DHL Express has launched DHL Medical Express Service (WMX) between Brazil and the United States for pharmaceutical and clinical research sector shippers. The transportation solution, piloted in Brazil, addresses increased demand for faster and more predictable lead times, given the regulatory complexities that can delay exports.

The service ultimately impacts clinical trial patients, as temperature-sensitive biological products and new patient-specific treatments will be in the right hands exactly when needed.

With its medical express service, DHL Express can manage the export and regulatory requirements for urgent shipments with specific temperature needs from several major cities in Brazil to most U.S. destinations in 24 to 48 hours. DHL has upgraded and validated its WMX service points in Brazil to meet several Brazilian federal, state, and city regulations around Ministry of Health and Sanitary controls and licensing requirements.